Clinical trial NCT01813266 - References

Chronic Hepatitis C Virus Infection — Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors

Citation(s)

•   Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ
  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006 May 16;144(10):705-14.
•   Chou R, Cottrell EB, Wasson N, Rahman B, Guise JM
  Screening for hepatitis C virus infection in adults: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2013 Jan 15;158(2):101-8. doi: 10.7326/0003-4819-158-2-201301150-00574
•   Chou R, Hartung D, Rahman B, Wasson N, Cottrell EB, Fu R
  Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review. Ann Intern Med. 2013 Jan 15;158(2):114-23. Review.
•   Duncan CJ, Stewart E, Fox R
  Improving targeted screening for hepatitis C in the UK. BMJ. 2012 Oct 3;345:e6525. doi: 10.1136/bmj.e6525.
•   Roblin DW, Smith BD, Weinbaum CM, Sabin ME
  HCV screening practices and prevalence in an MCO, 2000-2007. Am J Manag Care. 2011;17(8):548-55.
•   Sanyal AJ; Governing Board the Public Policy, Clinical Practice, Manpower committees of the AASLD
  The Institute of Medicine report on viral hepatitis: a call to action. Hepatology. 2010 Mar;51(3):727-8. doi: 10.1002/hep.23583.
•   Smith BD, Morgan RL, Beckett GA, Falck-Ytter Y, Holtzman D, Teo CG, Jewett A, Baack B, Rein DB, Patel N, Alter M, Yartel A, Ward JW; Centers for Disease Control and Prevention
  Recommendations for the identification of chronic hepatitis C virus infection
•   Southern WN, Drainoni ML, Smith BD, Christiansen CL, McKee D, Gifford AL, Weinbaum CM, Thompson D, Koppelman E, Maher S, Litwin AH
  Hepatitis C testing practices and prevalence in a high-risk urban ambulatory care setting. J Viral Hepat. 2011 Jul;18(7):474-81. doi: 10.1111/j.1365-2893.2010.01327.x. Epub 2010 May 20.
•   Sroczynski G, Esteban E, Conrads-Frank A, Schwarzer R, Mühlberger N, Wright D, Zeuzem S, Siebert U
  Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection. Eur J Public Health. 2009 Jun;19(3):245-53. doi: 10.1093/eurpu
•   Velázquez RF, Rodríguez M, Navascués CA, Linares A, Pérez R, Sotorríos NG, Martínez I, Rodrigo L
  Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology. 2003 Mar;37(3):520-7.

Prospective Cohort Study: To Provide Evidence & Guidance in Hepatitis C Virus Screening, Comparing the New Birth Cohort Recommendations From the CDC, Versus Classical Traditional Strategies With Established Risk Factors.

Details for clinical trial NCT01813266